Amyloid Cardiomyopathy Program

Program Overview

Boston Medical Center is an international referral center for the diagnosis and treatment of systemic amyloidosis, a rare group of diseases caused by the abnormal folding and then accumulation of protein in various parts of the body, including the heart. We are one of the few centers nationwide that offers innovative treatments for amyloidosis, including stem cell transplantation, with numerous ongoing clinical trials, for both the AL (primary) forms and AF (familial) forms. The Amyloid Cardiomyopathy Program employs a multidisciplinary approach to this multiorgan disorder. Our cardiologists diagnose and treat the damage amyloidosis can cause in the heart and coordinate innovative care with other specialists at Boston Medical Center. Areas of active clinical research relevant to cardiac amyloidosis include: cardiac imaging using magnetic resonance imaging (MRI), studies examining the biochemical basis of amyloid toxicity, and projects examining the best treatment of heart rhythm disturbances in patients with cardiac amyloidosis.

Back to top >

Contact Us

For further information, to refer a patient with amyloidosis to the Amyloid Cardiomyopathy Program, or for information regarding ongoing research studies, please contact the Program office at (617) 638-4317.

Boston University School of Medicine
72 East Concord Street, K-503
Boston, MA 02118
Phone: (617) 638-4317

Back to top >

Our Team

Frederick L. Ruberg, MD (amyloid cardiologist)
Hans Meier-Ewert, MD (amyloid cardiologist)
Flora Sam, MD (research)

Back to top >